Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 Generic Drugs

Business briefs: Pfizer, BMS, CMS, Sanofi

May 16, 2013

Pfizer cuts 136 workers loose in Ireland, BMS is investing in heart failure treatments, CMS has an official new leader, and Sanofi's iBGStar may have a competitor.
 

Business briefs: Angelina Jolie, adherence, Sanofi, Teva, AbbVie

May 14, 2013

Jolie takes on cancer awareness role, researchers identify another adherence gap, Sanofi gets slapped for scare tactics, Teva may compete for Adcock, AbbVie R&D chief leaves
 

Studies show cheaper drugs don't add up to greater use

May 09, 2013

Two studies released show that the story behind lower consumer healthspend isn't about generics improving health.
 

Business Briefs: GSK, Astellas, Vertex and Orexigen

April 22, 2013

GSK and Astellas kick off the race for a new anemia treatment; Orexigen's CEO joins PhRMA; BMS and Merck team up in a hep.-C clinical trial; Novartis lands glaucoma approval; Ireland starts naming preferred drugs; Novo has new New Jersey digs; Vertex releases promising data for new cystic fibrosis treatment.
 

Success in emerging markets hinges on broad network

April 03, 2013

Execs told Booz & Co researchers that the relationships web in emerging markets needs to be deeper than one-on-one sales pitches.
 

Court could punt "Pay for Delay" back to Congress

March 25, 2013

Eight members of the Supreme Court heard testimony in the case of FTC v. Actavis this morning, and the fate of so-called "pay for delay" settlements hangs in the balance.
 

Business briefs: Élan, Teva

February 25, 2013

A buyout offer upsets Elan's post-Tysabri plans, Takeda and Affymax recall Omontys.
 

Study finds docs suceptible to lunches, patient demands for branded drugs

January 08, 2013

Internists and small-office practitioners are also more likely to prescribe branded drugs than their professional peers.
 

Company news: AstraZeneca, Novartis, Teva

December 17, 2012

AstaZeneca avoids a Lipitor moment, FDA approves Novartis med for Cushing's, and Teva ventures into South Korea. Plus: a closer look at health exchanges
 

Teva says it will cut costs and innovate more

December 12, 2012

The drugmaker told investors Tuesday that generics will remain its standby, but novel therapeutic entities are also in its future.
 

AMA takes on generics and CME

November 13, 2012

The AMA's House of Delegates voted on measures including support for a ban on "pay-for-delay" deals and a recommendation that docs keep the the industry and CME separate.
 

People news: Teva

November 06, 2012

Teva names new president/CEO for Americas
 
  

Web Exclusive

Angelina Jolie's fearless but flawed message

Paul Oestreicher, Ph.D. May 17, 2013

Angelina Jolie's story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful
 

Podcasts

How to engage even the busiest physicians

March 04, 2013

Sponsored by TRUE Health + Wellness. The increasingly demanding schedules of healthcare professionals continue to narrow the window of opportunity for pharma sales teams, and, as a result, marketers are focusing more on non-personal promotion. However, there's a lot more to it than simply bombarding physicians with brand messages, as Anne Stroup, Managing Director at TRUE Health + Wellness, explains to MM&M's James Chase in this special podcast presentation.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Acquisition Adherence Advertising App Approval Centers For Disease Control Clinical Trial Consumer COPD Corporate Reputation Device Diabetes DTC Earnings Elan FDA Generic Generic Drugs iPad Marketing & Communications Mobile Obesity Patients Regulatory Wellness